A phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies Meeting Abstract
| Authors: | Lin, C. C.; Garralda, E.; Schoffski, P.; Hong, D.; Siu, L.; Martin, M.; Maur, M.; Hui, R.; Soo, R.; Chiu, J.; Zhang, T.; Ma, B.; Kyi, C.; Tan, D.; Cassier, P.; Sarantopoulos, J.; Weickhardt, A.; Carvajal, R.; Spratlin, J.; Esaki, T.; Rolland, F.; Akerley, W.; Deschler-Baier, B.; Sabatos-Peyton, C.; Chowdhury, N. R.; Gusenleitner, D.; Kwak, E.; Askoxylakis, V.; De Braud, F. |
| Abstract Title: | A phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A235 |
| Language: | English |
| ACCESSION: | WOS:000616665300376 |
| DOI: | 10.1136/jitc-2020-SITC2020.0387 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 387 -- Source: Wos |
